Obesity: a gender-view.
Creators
- 1. Dipartimento Di Medicina Clinica E Chirurgia, Diabetologia E Andrologia, Unità Di Endocrinologia, Università Degli Studi Di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. giovanna.muscogiuri@gmail.com.
- 2. University of Naples Federico II
- 3. Centro Italiano Per La Cura E Il Benessere del Paziente Con Obesità (C.I.B.O), Dipartimento Di Medicina Clinica E Chirurgia, Diabetologia E Andrologia, Unità Di Endocrinologia, Università Degli Studi Di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. giovanna.muscogiuri@gmail.com.
- 4. Cattedra Unesco "Educazione Alla Salute E Allo Sviluppo Sostenibile", University Federico II, Naples, Italy. giovanna.muscogiuri@gmail.com.
- 5. Centro Italiano Per La Cura E Il Benessere del Paziente Con Obesità (C.I.B.O), Dipartimento Di Medicina Clinica E Chirurgia, Diabetologia E Andrologia, Unità Di Endocrinologia, Università Degli Studi Di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy.
- 6. Department of Public Health, University of Naples Federico II, Naples, Italy.
- 7. Dipartimento Di Scienze Umanistiche, Centro Direzionale, Università Telematica Pegaso, Via PorzioIsola F2, 80143, Naples, Italy.
- 8. Dipartimento Di Medicina Clinica E Chirurgia, Diabetologia E Andrologia, Unità Di Endocrinologia, Università Degli Studi Di Napoli Federico II, Via Sergio Pansini 5, 80131, Naples, Italy.
- 9. Cattedra Unesco "Educazione Alla Salute E Allo Sviluppo Sostenibile", University Federico II, Naples, Italy.
Description
There is a growing awareness of the importance of understanding gender differences in obesity. The aim of this short review was to revise the current evidence on anthropometric characteristics and nutritional and pharmacological aspects of obesity from a gender perspective.
A literature search within PubMed was performed. Selected publications related to obesity and gender differences were reviewed.
The prevalence of obesity among men is higher than in women, but women have a higher percentage of body fat content compared to men, and gender appears to be an important factor in the manifestation of central (android) or peripheral (gynoid) obesity. In addition, while in most clinical trials, women are still underrepresented, in clinical registration trials of anti-obesity drugs, women are commonly up-represented and gender-specific analysis is uncommon. Considering that adipose tissue is one of the factors affecting the volume of distribution of many drugs, mainly lipophilic drugs, gender differences might be expected in the pharmacokinetics and pharmacodynamics of anti-obesity drugs. Indeed, although Liraglutide 3 mg, a long-acting glucagon-like peptide-1 receptor agonist, and naltrexone/bupropion display lipophilic properties, currently, a gender-dose adjustment for both these drugs administration is not recommended. In addition, despite that predicted responders to treatment offer substantial opportunities for efficient use, especially of expensive new therapies, such as anti-obesity drugs, data on gender differences to identify early responders to both these have not yet been investigated. Finally, bariatric surgery gender disparity reflects healthcare practices. Weight loss similar, but differing effects: women need more correction and face psychology challenges; men have worse physiology and fewer comorbidity improvements.
Gender differences exist in obesity prevalence and phenotype, body fat distribution, drug efficacy, clinical trial representation, and different secondary effects of bariatric surgery. Gender is an important variable in obesity analysis.
© 2023. The Author(s).
Open Access
Licence Attribution (CC BY)
Publisher Website
Access full text
Publication Details
Journal article
Journal:
Journal of endocrinological investigation
Publisher:
Springer Science and Business Media LLC
ISSN:
17208386
Volume:
47
Pages:
299-306
Persistent Identifiers
Funding
Financial Support
Università degli Studi di Napoli Federico II
Read more
References
Porter SJ, Somogyi AA, White JM (2000) Kinetics and inhibition of the formation ...
Read more
Williams RL, Wood LG, Collins CE, Callister R (2015) Effectiveness of weight los...
Read more
Karastergiou K, Smith SR, Greenberg AS, Fried SK (2012) Sex differences in human...
Read more
Chang E, Varghese M, Singer K (2018) Gender and sex differences in adipose tissu...
Read more
Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A et al (2003) Estrad...
Read more
Showing first 5 of 64 references.
Scholarly Citations
MeSH Terms
MeSH (Medical Subject Headings) is the NLM controlled vocabulary for indexing biomedical articles.
Click any term to view its definition and hierarchy.
Chemical Substances
2 chemical substances identified from Medical Subject Headings (MeSH).